Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.
Press releases published on August 7, 2025
Full Alliance Group's Quant Blockchain Developing HIPAA-Compliant Healthcare Data Sharing Solution
GlobeNewswire
·
August 7, 2025
TAMPA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) announced today that its Qubitera Holdings subsidiary is developing breakthrough technology that will help hospitals and healthcare systems share patient information …
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
GlobeNewswire
·
August 7, 2025
The final cohort of the single ascending dose (SAD) part of the Phase 1 AVALON trial initiated, with the SAD data readout expected early in the fourth quarter of 2025; The multiple ascending dose (MAD) part of the AVALON trial initiated; Available …
UroGen Pharma Expands Commercial Portfolio with Launch of ZUSDURI™ and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
ZUSDURI™ (mitomycin) for intravesical solution now available as the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) JELMYTO® achieved net product sales of $24.2 …
Fiverr Releases Its 2024 Impact Report
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Fiverr International Ltd. (NYSE: FVRR) released its 2024 Impact Report, detailing the actions taken in 2024 to ensure a more sustainable future and introducing new goals that are aligned with Fiverr’s key pillars …
Replimune Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 7, 2025
WOBURN, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal first quarter …
Maxus Mining Initiates 2025 Exploration Program on the Penny Copper Project, British Columbia
GlobeNewswire
·
August 7, 2025
VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce the commencement of the Company’s 2025 exploration program (the “Program”) on its Penny Copper …
Critical Metals Corp Engages Global Engineering Firm NIRAS to Finalize DFS for Tanbreez in Greenland
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp (NASDAQ: CRML) (“the Company”), a leading critical minerals mining company, is pleased to announce that Tanbreez Mining Greenland A/S (“Tanbreez”), has appointed NIRAS A/S (“NIRAS”), a …
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
GlobeNewswire
·
August 7, 2025
Vancouver, Canada, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
INF904 Phase 2a data in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected by the end of September to early November 2025 Phase 1/2 data announced by Staidson BioPharmaceuticals for InflaRx-partnered C5a antibody BDB-001 in ANCA …
Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025
GlobeNewswire
·
August 7, 2025
PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based therapeutics for the …
Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
– Registrational cohort enrollment in RESET-Myositis™ trial on track to start in 2H25 with anticipated 2027 BLA submission for rese-cel in myositis – – Five disease-specific cohorts fully enrolled in the RESET™ clinical development program from over 70 …
Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
GlobeNewswire
·
August 7, 2025
SEATTLE and VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Verano Announces Resignation of Company President Darren Weiss
GlobeNewswire
·
August 7, 2025
CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the resignation of Darren Weiss from his role as Company President to …
ProQR Announces Second Quarter 2025 Operating and Financial Results
GlobeNewswire
·
August 7, 2025
Submitted CTA for lead program AX-0810, targeting NTCP for cholestatic diseases Advancing AX-2402 program toward clinical candidate selection, targeting MECP2 (R270X) for Rett Syndrome Hosting fall Analyst and Investor Event (virtual), featuring detailed …
Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
GlobeNewswire
·
August 7, 2025
Second quarter performance driven by strong portfolio royalty revenue growth of 57% 2025 full year revenue guidance increased to $200 million - $225 million (previously $180 million - $200 million) and adjusted earnings per diluted share1 increased to $6. …
NexGold Intersects 23.73 g/t Gold over 5.3 Metres and 24.65 g/t Gold over 2.2 Metres at the Goldboro Open Pit Gold Project
GlobeNewswire
·
August 7, 2025
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide additional drill results from a recently-completed 26,854-metre diamond drill program initially announced on …
Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update
GlobeNewswire
·
August 7, 2025
RAP-219 Phase 2a trial in patients with drug-resistant focal onset seizures is fully enrolled and on track for topline results in September 2025 Phase 2 trial of RAP-219 in bipolar mania has been initiated and is enrolling patients; trial remains on track, …
Aya Gold & Silver Receives US$8 Million in Compensation Related to Zgounder Expansion
GlobeNewswire
·
August 7, 2025
MONTREAL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) announces that its subsidiary, Zgounder Millenium Silver Mining (“ZMSM”), has received a payment of approximately US$8 million under …
Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
‒ Q2 2025 Net Revenue of $39.7mm; Net Income of $19.8mm; Adjusted EBITDA of $22.4mm ‒ ‒ Company Announces Acquisition of Melinta Therapeutics ‒ ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time ‒ BERKELEY HEIGHTS, N.J., Aug. 07, 2025 (GLOBE …
Surge Copper Announces Commencement of 2025 Field Program at Berg Project
GlobeNewswire
·
August 7, 2025
Vancouver, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to provide an update on its 2025 field program, which commenced in mid-July at the Company …